GET DAILY SIGNALSKimball Electronics (KE) Reports +7% Revenue Growth in Q1 Fiscal 2027
Key Takeaways
- Kimball Electronics returned to top-line growth in the first quarter of fiscal 2027, with net sales rising 7% year over year to $390.8 million.
- Adjusted diluted earnings per share (EPS) of $0.25 came in below Wall Street's consensus of roughly $0.38, while revenue modestly beat the forecast of about $385.7 million.
- The medical vertical led the way, climbing 14%, while automotive and industrial sales rose 4% and 5%, respectively.
- Adjusted operating margin narrowed to 4.3% from 4.8% a year earlier, as higher selling and administrative expenses and acquisition-related costs weighed on profitability.
- Management reiterated fiscal 2027 guidance, saying net sales are now expected at the high end of the $1,535–$1,560 million range.
- For more detail, review the company's Major News, Today's Price Move, Price Targets, and Forecast pages.
- Explore Trending AI Robots to see how automated strategies are positioning across the market.
Earnings Context and Why It Matters
Kimball Electronics serves as a global provider of Electronics Manufacturing Services (EMS) and Contract Development and Manufacturing Organization (CDMO) solutions for automotive, medical, and industrial clients. After fiscal 2026, which management described as a "year of transition," this quarter offered a clear test of whether the company's strategic shifts, especially the push into medical offerings, could drive renewed revenue growth. The results carry extra significance as the first to reflect contributions from the Helvoet Polymer Technologies acquisition in the medical CDMO space. I reviewed the company's performance using Tickeron’s AI Daily Buy/Sell Signals to gauge broader sentiment around the name. Investors focused on whether demand trends and the balance-sheet improvements built through 2026 would support sustainable, profitable progress.
Reported Results
For the first quarter of fiscal 2027 ended September 30, 2026, KE posted net sales of $390.8 million, up 7% from $365.6 million a year earlier and slightly ahead of the consensus estimate of roughly $385.7 million. Organic sales grew 3%, with the Helvoet acquisition adding about $12.4 million in revenue.
On a GAAP basis, net income totaled $2.6 million, or $0.11 per diluted share, compared with $10.1 million, or $0.40 per diluted share, in the prior-year quarter. Adjusted diluted EPS, which excludes acquisition amortization, stock compensation, and restructuring items, reached $0.25 versus $0.49 a year ago and below the consensus of about $0.38.
By vertical, medical sales increased 14% to $115.7 million, automotive rose 4% to $170.5 million, and industrial advanced 5% to $104.6 million. Adjusted operating income came in at $17.0 million, or 4.3% of sales, versus $17.5 million, or 4.8%, in the year-ago period. Management kept its fiscal 2027 outlook for net sales of $1,535–$1,560 million, adjusted operating margin of 4.4%–4.7%, and capital expenditures of $50–$60 million, with sales now projected at the high end of the range.
Market Reaction and Investor Sentiment
Shares of KE declined roughly 3% after the report as investors balanced the return to revenue growth against the earnings shortfall. The modest revenue beat and 14% jump in medical sales highlighted improving demand, yet the earnings miss—tied to higher selling and administrative costs plus acquisition expenses—limited the positive reaction. Pre-report sentiment had been cautiously optimistic, centered on whether the company could maintain momentum after ten straight quarters of positive operating cash flow through fiscal 2026. Negative cash flow from operations this quarter, partly due to the Helvoet deal and working-capital needs, introduced additional caution around the pace of reinvestment.
Forward Outlook and Key Factors to Monitor
Looking ahead, attention will turn to whether KE can sustain fiscal 2027 guidance at the high end of the sales range while steadying margins. Management anticipates organic growth of 3%–5%, with medical expanding at a high-single to low-double-digit pace, supported by ongoing demand in that vertical and progress at the Indianapolis facility.
Integration of Helvoet Polymer Technologies stands out as a key variable. The deal is expected to be accretive and adds roughly $60 million in annual sales, yet it brings amortization and integration costs that weighed on near-term results. Other items to track include the path of selling and administrative expenses, cash conversion days, and any relief in working-capital demands from higher customer inventory requests. Automotive and industrial conditions, especially around electric vehicles and climate controls, will also shape the recovery pace, along with updates on capital spending and potential guidance shifts.
Using AI Tools in My Research Process
When evaluating names like KE in the EMS and CDMO space, I often rely on Tickeron’s AI Screener to quickly scan for technical patterns, fundamentals, and industry trends. It streamlines the process of comparing peers and spotting opportunities without hours of manual work. This approach has helped me refine views on how acquisition impacts and vertical growth play out over time.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
KE sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for KE moved above the 200-day moving average on October 20, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KE's RSI Indicator exited the oversold zone, 24 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on KE as a result. In 58 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
KE moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where KE advanced for three days, in 234 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
KE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 133 of 191 cases where KE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 57 cases where KE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for KE turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 37 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
The 10-day moving average for KE crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.094) is normal, around the industry mean (2.863). P/E Ratio (23.430) is within average values for comparable stocks, (11.311). Projected Growth (PEG Ratio) (1.176) is also within normal values, averaging (2.910). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (9.055).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. KE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
How to use the average directional index in trading?
What Is Full Retirement Age (FRA) and How Does It Impact Your Social Security Benefits?
XOM, CVX, SHEL, IMO, APO, CBOE, DD, WEN, CI, NWG | Q1 2025 Earnings Preview: Friday, May 2, 2025
Top Wind Energy Stocks
FAQ: How does the Tickeron AI Screener function?
General Information
a provider of engineering, manufacturing and supply chain services
Industry ElectricalProducts
Advertisement